Literature DB >> 2056770

bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient.

D C van der Plas1, D Soekarman, A M van Gent, G Grosveld, A Hagemeijer.   

Abstract

Using the polymerase chain reaction and Southern blot analysis the expression was detected of a bcr-abl mRNA lacking abl exon a2. This was due to a corresponding unusual localization of the breakpoint in the c-abl gene and was seen in a patient with Philadelphia (Ph) chromosome positive chronic myelogeneous leukemia in chronic phase. This type of mRNA has been described only once before in two Ph-positive acute lymphoblastic leukemia patients, by Soekarman et al. (1). The abl exon a2 sequences, which are missing in the three reported patients, code for a part of the SH3 region of the abl protein, which is supposed to be involved in negative regulation of the kinase domain. The clinical significance of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056770

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  A rare e14a3 (b3a3) BCR-ABL fusion transcript in chronic myeloid leukemia: diagnostic challenges in clinical laboratory practice.

Authors:  Natini Jinawath; Alexis Norris-Kirby; B Douglas Smith; Christopher D Gocke; Denise A Batista; Constance A Griffin; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2009-06-04       Impact factor: 5.568

Review 2.  Monitoring bcr-abl by polymerase chain reaction in the treatment of chronic myeloid leukemia.

Authors:  Vivian G Oehler; Jerald P Radich
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 3.  A variant transcript, e1a3, of the minor BCR-ABL fusion gene in acute lymphoblastic leukemia: case report and review of the literature.

Authors:  Shinya Fujisawa; Satoki Nakamura; Kensuke Naito; Masahide Kobayashi; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2008-02-06       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.